{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:40:12Z","timestamp":1791830412728,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Orel State University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.steroids.2020.108661","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T21:33:15Z","timestamp":1590183195000},"page":"108661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Hepcidin, an overview of biochemical and clinical properties"],"prefix":"10.1016","volume":"160","author":[{"given":"Abdur","family":"Rauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Shariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anees Ahmed","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud","family":"Bawazeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Plygun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexy","family":"Laishevtcev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bilal","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad A.","family":"Alhumaydhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S.M.","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2020.108661_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood-2003-03-0672","article-title":"Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation","volume":"102","author":"Ganz","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.steroids.2020.108661_b0010","doi-asserted-by":"crossref","unstructured":"E.H. Kemna, H. Tjalsma, H.L. Willems, D.W. Swinkels DW. Hepcidin: from discovery to differential diagnosis, Haematologica. 93(2008) 0-7.","DOI":"10.3324\/haematol.11705"},{"key":"10.1016\/j.steroids.2020.108661_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jnutbio.2007.11.008","article-title":"Hepcidin, interleukin-6 and hematological iron markers in males before and after heart surgery","volume":"20","author":"Hoppe","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.steroids.2020.108661_b0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ab.2008.09.045","article-title":"Quantitation of hepcidin in human urine by liquid chromatography-mass spectrometry","volume":"384","author":"Bansal","year":"2009","journal-title":"Anal Biochem."},{"key":"10.1016\/j.steroids.2020.108661_b0025","first-page":"165","article-title":"Hepcidin: A key iron regulator involved in the pathogenesis of anaemia of chronic disease","volume":"7","author":"Politou","year":"2004","journal-title":"Haema."},{"key":"10.1016\/j.steroids.2020.108661_b0030","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/ndt\/gfn267","article-title":"Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?","volume":"23","author":"Swinkels","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.steroids.2020.108661_b0035","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2008.05.014","article-title":"Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion","volume":"49","author":"Fujita","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.steroids.2020.108661_b0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.nut.2008.11.030","article-title":"Vitamin A deficiency increases hepcidin expression and oxidative stress in rat","volume":"25","author":"Arruda","year":"2009","journal-title":"Nut."},{"key":"10.1016\/j.steroids.2020.108661_b0045","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.bmcl.2015.03.012","article-title":"Small cyclic agonists of iron regulatory hormone hepcidin","volume":"25","author":"Kristine","year":"2015","journal-title":"Bioor. Medic. Chem. Letters."},{"key":"10.1016\/j.steroids.2020.108661_b0050","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science."},{"key":"10.1016\/j.steroids.2020.108661_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ncpgasthep0019","article-title":"Mechanisms of disease: The role of hepcidin in iron homeostasis\u2013implications for hemochromatosis and other disorders","volume":"1","author":"Pietrangelo","year":"2004","journal-title":"Nat. Clin. Pract. Gastroenterol, Hepatol."},{"key":"10.1016\/j.steroids.2020.108661_b0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/psc.1113","article-title":"Synthesis of hepcidin derivatives in order to develop standards for immune adsorptionmethod","volume":"15","author":"Balogh","year":"2009","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.steroids.2020.108661_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcmd.2007.07.009","article-title":"Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin","volume":"40","author":"Valore","year":"2008","journal-title":"Blood. Cells. Mol. Dis."},{"key":"10.1016\/j.steroids.2020.108661_b0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1742-4658.2009.06937.x","article-title":"Alpha-1 antitrypsin binds preprohepcidin intracellularly and prohepcidin in the serum","volume":"276","author":"Pandur","year":"2009","journal-title":"FEBS. J."},{"key":"10.1016\/j.steroids.2020.108661_b0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1074\/jbc.M205305200","article-title":"The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis","volume":"277","author":"Hunter","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2009","key":"10.1016\/j.steroids.2020.108661_b0080","first-page":"55","article-title":"Hepcidin revisited, disulfide connectivity, dynamics, and structure","volume":"284","author":"Jordan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2020.108661_b0085","first-page":"124","article-title":"Hepcidin and its role in iron homeostasis","volume":"25","author":"Kwapisz","year":"2009","journal-title":"EJIFCC."},{"key":"10.1016\/j.steroids.2020.108661_b0090","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"Park","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2020.108661_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.steroids.2020.108661_b0100","first-page":"47","article-title":"Hepcidin the iron regulatory hormone","volume":"26","author":"Rossi","year":"2005","journal-title":"Clin Biochem Rev."},{"key":"10.1016\/j.steroids.2020.108661_b0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2005-05-2049","article-title":"The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study","volume":"107","author":"Nemeth","year":"2006","journal-title":"BLOOD"},{"key":"10.1016\/j.steroids.2020.108661_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082271","article-title":"Investigations of the Copper Peptide Hepcidin-25 by LC-MS\/MS and NMR","volume":"19","author":"Abbas","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.steroids.2020.108661_b0115","doi-asserted-by":"crossref","first-page":"9272","DOI":"10.1074\/jbc.M411154200","volume":"280","author":"Lauth","year":"2005","journal-title":"Biol. Chem."},{"key":"10.1016\/j.steroids.2020.108661_b0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2008-03-146134","article-title":"The molecular basis of hepcidin-resistant hereditary hemochromatosis","volume":"114","author":"Fernandes","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.steroids.2020.108661_b0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2009.03.006","article-title":"A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression","volume":"9","author":"Zhan","year":"2009","journal-title":"Cell. Metab."},{"key":"10.1016\/j.steroids.2020.108661_b0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta. Haematol."},{"key":"10.1016\/j.steroids.2020.108661_b0135","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1172\/JCI67225","article-title":"Iron regulation by hepcidin","volume":"123","author":"Zhao","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2020.108661_b0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","article-title":"Specificity and versatility in tgf-beta signaling through Smads","volume":"21","author":"Feng","year":"2005","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"10.1016\/j.steroids.2020.108661_b0145","first-page":"218","article-title":"Current status of iron metabolism: Clinical and therapeutic implications","volume":"148","author":"Diez","year":"2017","journal-title":"Med. Cl\u00edn."},{"key":"10.1016\/j.steroids.2020.108661_b0150","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.161296298","article-title":"Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease","volume":"98","author":"Fleming","year":"2001","journal-title":"Proceed. Nat. Academy. Sci. USA"},{"key":"10.1016\/j.steroids.2020.108661_b0155","article-title":"Small cyclic agonists of iron regulatory hormone hepcidin","volume":"4961\u20134969","author":"Chua","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.steroids.2020.108661_b0160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2362.2010.02291.x","article-title":"Hepcidin treatment in Hfe\u2212\/\u2212 mice diminishes plasma iron without affecting erythropoiesis","volume":"40","author":"Moran-Jimenez","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.steroids.2020.108661_b0165","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bmcl.2014.12.094","article-title":"Thiol-derivatized minihepcidins retain biological activity","volume":"25","author":"Fung","year":"2015","journal-title":"Bioor. Medic. Chem. Letters."},{"key":"10.1016\/j.steroids.2020.108661_b0170","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1172\/JCI57693","article-title":"Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload","volume":"121","author":"Preza","year":"2001","journal-title":"J. Clinic. Investig."},{"key":"10.1016\/j.steroids.2020.108661_b0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ki.2011.141","article-title":"Hepcidin: clinical utility as a diagnostic tool and therapeutic target","volume":"80","author":"Coyne","year":"2011","journal-title":"Kidney. Int."},{"key":"10.1016\/j.steroids.2020.108661_b0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000480743","article-title":"Clinical Implications of New Insights into Hepcidin-Mediated Regulation of Iron Absorption and Metabolism","volume":"71","author":"Prentice","year":"2017","journal-title":"Annals. Nut. Meta."},{"key":"10.1016\/j.steroids.2020.108661_b0185","first-page":"41","article-title":"Iron mobilization and pharmacodynic marker measurements in non-human primates following administration of PRS-080, a novel and highly specific anti-hepcidin therapeutic","volume":"88","author":"Hohlbaum","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.steroids.2020.108661_b0190","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2215\/CJN.02190309","article-title":"Hepcidin for clinicians","volume":"4","author":"Young","year":"2009","journal-title":"Clinic. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.steroids.2020.108661_b0195","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1097\/MD.0000000000003150","article-title":"Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review","volume":"95","author":"Liu","year":"2016","journal-title":"Med."},{"key":"10.1016\/j.steroids.2020.108661_b0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpendmet0716","article-title":"Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity","volume":"4","author":"Adams","year":"2008","journal-title":"Nature clinical practice. Endocri. Meta."},{"key":"10.1016\/j.steroids.2020.108661_b0205","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.clnu.2016.06.015","article-title":"High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults","volume":"36","author":"Smith","year":"2017","journal-title":"Clini. Nut."},{"key":"10.1016\/j.steroids.2020.108661_b0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12882-018-0823-7","article-title":"Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: a randomized controlled trial","volume":"19","author":"Panwar","year":"2018","journal-title":"BMC. Nephro."},{"key":"10.1016\/j.steroids.2020.108661_b0215","first-page":"190","article-title":"MAVIDOS Trial Group The Effect of Vitamin D Supplementation on Hepcidin, Iron Status, and Inflammation in Pregnant Women in the United Kingdom","volume":"11","author":"Braithwaite","year":"2019","journal-title":"Nutr."},{"key":"10.1016\/j.steroids.2020.108661_b0220","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1159\/000481976","article-title":"Association of maternal serum 25-hydroxyvitamin D concentrations with risk of gestational anemia","volume":"43","author":"Yuan","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.steroids.2020.108661_b0225","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1017\/S0007114515000999","article-title":"Vitamin D deficiency is associated with anaemia among african americans in a us cohort","volume":"113","author":"Smith","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.steroids.2020.108661_b0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5045\/br.2013.48.1.40","article-title":"The prevalence of vitamin d deficiency in iron-deficient and normal children under the age of 24 months","volume":"48","author":"Jin","year":"2013","journal-title":"Blood Res."},{"key":"10.1016\/j.steroids.2020.108661_b0235","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood-2010-09-309708","article-title":"Prevalence of 25-hydroxyvitamin d deficiency in subgroups of elderly persons with anemia: Association with anemia of inflammation","volume":"117","author":"Perlstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.steroids.2020.108661_b0240","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cca.2013.02.025","article-title":"Low vitamin d levels increase anemia risk in korean women","volume":"421","author":"Shin","year":"2013","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.steroids.2020.108661_b0245","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3945\/ajcn.115.116756","article-title":"Vitamin D status is inversely associated with anemia and serum erythropoietin during pregnancy","volume":"102","author":"Thomas","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.steroids.2020.108661_b0250","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2147\/IJWH.S51403","article-title":"Association between vitamin D insufficiency and adverse pregnancy outcome: Global comparisons","volume":"5","author":"Bener","year":"2013","journal-title":"Int. J. Womens Health."},{"key":"10.1016\/j.steroids.2020.108661_b0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5414\/CN107018","article-title":"Hepcidin and disordered mineral metabolism in chronic kidney disease","volume":"76","author":"Carvalho","year":"2011","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.steroids.2020.108661_b0260","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/nep.12815","article-title":"Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial","volume":"22","author":"Gummer","year":"2017","journal-title":"Nephro."},{"key":"10.1016\/j.steroids.2020.108661_b0265","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/asheducation-2011.1.538","article-title":"The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders","author":"Ganz","year":"2011","journal-title":"Hematology, Am. Soc. Hematol. Ed. Prog."},{"key":"10.1016\/j.steroids.2020.108661_b0270","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hoc.2013.11.004","article-title":"Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches","volume":"28","author":"Schmidt Fleming","year":"2014","journal-title":"Hemato\/onco. Clin. North. Am."},{"key":"10.1016\/j.steroids.2020.108661_b0275","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1182\/blood-2004-12-4844","article-title":"Hepcidin in iron overload disorders","volume":"105","author":"Papanikolaou","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.steroids.2020.108661_b0280","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/ptr.6118","article-title":"An investigation of the effects of curcumin on iron overload, hepcidin level, and liver function in beta-thalassemia major patients: A double-blind randomized controlled clinical trial","volume":"32","author":"Mohammadi","year":"2018","journal-title":"Phytother. Res."},{"key":"10.1016\/j.steroids.2020.108661_b0285","doi-asserted-by":"crossref","unstructured":"M.A. Atkinson S.P. Juraschek M.S. Bertenthal B. Detrick S.L. Furth E.R. Miller ER, Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial Pediat. Nephrol. 32 2017 859 868.","DOI":"10.1007\/s00467-016-3563-6"},{"key":"10.1016\/j.steroids.2020.108661_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157063","article-title":"Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial","volume":"11","author":"Gaillard","year":"2016","journal-title":"PloS one."},{"key":"10.1016\/j.steroids.2020.108661_b0295","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/vox.12348","article-title":"Effects of oral supplementation of iron on hepcidin blood concentrations among non-anaemic female blood donors: a randomized controlled trial","volume":"110","author":"Waldvogel","year":"2016","journal-title":"Vox. Sanguinis."},{"key":"10.1016\/j.steroids.2020.108661_b0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3945\/ajcn.2010.29185","article-title":"Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation","volume":"92","author":"Karl","year":"2010","journal-title":"Am. J. Clin. Nut."},{"key":"10.1016\/j.steroids.2020.108661_b0305","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.151179498","article-title":"Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice","volume":"98","author":"Nicolas","year":"2001","journal-title":"Proceed. National. Academy. Sci."},{"key":"10.1016\/j.steroids.2020.108661_b0310","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J. Bio. Chem."},{"key":"10.1016\/j.steroids.2020.108661_b0315","doi-asserted-by":"crossref","unstructured":"E. Nemeth E.V. Valore M. Territo G. Schiller A. Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood. 101 2003 2461 2463.","DOI":"10.1182\/blood-2002-10-3235"},{"key":"10.1016\/j.steroids.2020.108661_b0320","article-title":"Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia, J.C.I","volume":"26","author":"Michels","year":"2017","journal-title":"Insight."},{"key":"10.1016\/j.steroids.2020.108661_b0325","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","article-title":"Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein","volume":"101","author":"Nemeth","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.steroids.2020.108661_b0330","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/IAI.74.5.3065-3067.2006","article-title":"The Iron Efflux Protein Ferroportin Regulates the Intracellular Growth of Salmonella enterica","volume":"74","author":"Chlosta","year":"2006","journal-title":"Infec. Immu."},{"key":"10.1016\/j.steroids.2020.108661_b0335","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1182\/blood-2009-05-223354","article-title":"Absence of functional Hfe protects mice from invasive Salmonella enterica Serovar Typhimurium infection via induction of lipocalin-2","volume":"114","author":"Nairz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.steroids.2020.108661_b0340","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm.3483","article-title":"Inverse agonist of estrogen-related receptor [gamma] controls Salmonella typhimurium infection by modulating host iron homeostasis","volume":"20","author":"Kim","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.steroids.2020.108661_b0345","doi-asserted-by":"crossref","first-page":"55331","DOI":"10.1371\/journal.pone.0055331","article-title":"Suppression of Hepcidin Expression and Iron Overload Mediate Salmonella Susceptibility in Ankyrin 1 ENU-Induced Mutant","volume":"8","author":"Yuki","year":"2013","journal-title":"PloS one."},{"key":"10.1016\/j.steroids.2020.108661_b0350","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.181.4.2723","article-title":"Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation","volume":"181","author":"Wang","year":"2008","journal-title":"J. Immuno."},{"key":"10.1016\/j.steroids.2020.108661_b0355","doi-asserted-by":"crossref","unstructured":"V.R. Gordeuk, C.E. McLaren, A.P. MacPhail, G. Deichsel, T.H. Bothwell, Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited, Blood. 87 (1996) 3470\u20133476.","DOI":"10.1182\/blood.V87.8.3470.bloodjournal8783470"},{"key":"10.1016\/j.steroids.2020.108661_b0360","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/518040","article-title":"The effect of the host's iron status on tuberculosis","volume":"195","author":"Boelaert","year":"2007","journal-title":"J. Inf. Diseas."},{"key":"10.1016\/j.steroids.2020.108661_b0365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1189\/jlb.0606405","article-title":"Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages","volume":"81","author":"Olakanmi","year":"2007","journal-title":"J. Leukocyte. Bio."},{"key":"10.1016\/j.steroids.2020.108661_b0370","doi-asserted-by":"crossref","first-page":"49727","DOI":"10.1074\/jbc.M209768200","article-title":"Intraphagosomal Mycobacterium tuberculosis Acquires Iron from Both Extracellular Transferrin and Intracellular Iron Pools: impact of interferon-\u03b3 and hemochromatosis","volume":"277","author":"Olakanmi","year":"2002","journal-title":"J. Bio. Chem."},{"key":"10.1016\/j.steroids.2020.108661_b0375","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/IAI.00612-08","article-title":"Increased Susceptibility to Mycobacterium avium in Hemochromatosis Protein HFE-Deficient Mice","volume":"76","author":"Gomes-Pereira","year":"2008","journal-title":"Infec. Immun."},{"key":"10.1016\/j.steroids.2020.108661_b0380","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1128\/IAI.00498-10","article-title":"Role of Ferroportin in Macrophage-Mediated Immunity","volume":"78","author":"Johnson","year":"2010","journal-title":"Infec. Immun."},{"key":"10.1016\/j.steroids.2020.108661_b0385","doi-asserted-by":"crossref","unstructured":"K.E. Van Zandt, F.B. Sow, W.C. Florence, B.S. Zwilling, A.R. Satoskar, L.S. Schlesinger, The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome, J. Leukocyte. Bio. 84 (200) 689\u2013700.","DOI":"10.1189\/jlb.1107781"},{"key":"10.1016\/j.steroids.2020.108661_b0390","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0035-9203(86)90154-9","article-title":"Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea","volume":"80","author":"Oppenheimer","year":"1986","journal-title":"Transact. Royal. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.steroids.2020.108661_b0395","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/jn\/134.11.3037","article-title":"Low-dose daily iron supplementation for 12 months does not increase the prevalence of malarial infection or density of parasites in young Zanzibari children","volume":"134","author":"Mebrahtu","year":"2004","journal-title":"J. Nut."},{"key":"10.1016\/j.steroids.2020.108661_b0400","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(97)04229-3","article-title":"Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants","volume":"350","author":"Menendez","year":"1997","journal-title":"The Lancet."},{"key":"10.1016\/j.steroids.2020.108661_b0405","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/cid\/cis010","article-title":"Iron Deficiency Protects Against Severe Plasmodium falciparum Malaria and Death in Young Children","volume":"54","author":"Gwamaka","year":"2012","journal-title":"Clin. Infect."},{"key":"10.1016\/j.steroids.2020.108661_b0410","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1086\/589512","article-title":"Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency","volume":"198","author":"Kabyemela","year":"2008","journal-title":"J. Infect."},{"key":"10.1016\/j.steroids.2020.108661_b0415","doi-asserted-by":"crossref","unstructured":"A.M. Nyakeriga M. Troye-Blomberg J.R. Dorfman N.D. Alexander R. B\u00e4ck M. Kortok M. Iron deficiency and malaria among children living on the coast of Kenya J. Infect. 190 2004 439 444.","DOI":"10.1086\/422331"},{"key":"10.1016\/j.steroids.2020.108661_b0420","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbrc.2007.03.175","article-title":"Iron deficiency influences the course of malaria in Plasmodium berghei infected mice","volume":"357","author":"Koka","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.steroids.2020.108661_b0425","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/eji.201040942","article-title":"A critical role for phagocytosis in resistance to malaria in iron-deficient mice","volume":"41","author":"Matsuzaki-Moriya","year":"2011","journal-title":"Eur. J. Immun."},{"key":"10.1016\/j.steroids.2020.108661_b0430","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3324\/haematol.2012.065854","article-title":"Hepcidin demonstrates a biphasic association with anemia in acute Plasmodium falciparum malaria","volume":"97","author":"Casals-Pascual","year":"2012","journal-title":"Haematol."},{"key":"10.1016\/j.steroids.2020.108661_b0435","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/595790","article-title":"Assessment of Urinary Concentrations of Hepcidin Provides Novel Insight into Disturbances in Iron Homeostasis during Malarial Infection","volume":"199","author":"de Mast","year":"2009","journal-title":"J. Infect."},{"key":"10.1016\/j.steroids.2020.108661_b0440","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nm.2368","article-title":"Host mediated regulation of superinfection in malaria","volume":"17","author":"Portugal","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.steroids.2020.108661_b0445","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.4049\/jimmunol.1101436","article-title":"Hepcidin is regulated during blood-stage malaria and plays a protective role in malaria infection","volume":"187","author":"Wang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.steroids.2020.108661_b0450","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2141.2009.07880.x","article-title":"Plasmodium falciparum infected erythrocytes induce hepcidin (HAMP) mRNA synthesis by peripheral blood mononuclear cells","volume":"147","author":"Armitage","year":"2009","journal-title":"British. J. Haematol."},{"key":"10.1016\/j.steroids.2020.108661_b0455","article-title":"Interleukin-10 Regulates Hepcidin in Plasmodium Falciparum Malaria","volume":"9","author":"Huang","year":"2004","journal-title":"PloS. one."},{"key":"10.1016\/j.steroids.2020.108661_b0460","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1475-2875-10-47","article-title":"Reduced risk for placental malaria in iron deficient women","volume":"10","author":"Senga","year":"2011","journal-title":"Malaria J."},{"key":"10.1016\/j.steroids.2020.108661_b0465","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1475-2875-11-249","article-title":"Zinc erythrocyte protoporphyrin as marker of malaria risk in pregnancy \u2013 a retrospective cross-sectional and longitudinal study","volume":"11","author":"Senga","year":"2012","journal-title":"Malar. J"},{"key":"10.1016\/j.steroids.2020.108661_b0470","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphar.2014.00125","article-title":"Iron, anemia and hepcidin in malaria","volume":"5","author":"Spottiswoode","year":"2014","journal-title":"Front. pharmacol."},{"key":"10.1016\/j.steroids.2020.108661_b0475","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chom.2014.12.001","article-title":"Hepcidin-Induced Hypoferremia Is a Critical Host Defense Mechanism against the Siderophilic Bacterium Vibrio vulnificus","volume":"7","author":"Arezes","year":"2015","journal-title":"Cell. Host. Microbe."},{"key":"10.1016\/j.steroids.2020.108661_b0480","article-title":"Hepcidin and host defense against infectious diseases","volume":"11","author":"Michel","year":"2015","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.steroids.2020.108661_b0485","doi-asserted-by":"crossref","first-page":"1003901","DOI":"10.1371\/journal.ppat.1003901","article-title":"Leishmania-Mediated Inhibition of Iron Export Promotes Parasite Replication in Macrophages","volume":"10","author":"Ben-Othman","year":"2014","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.steroids.2020.108661_b0490","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood-2007-12-126854","article-title":"Iron depletion limits intracellular bacterial growth in macrophages","volume":"112","author":"Paradkar","year":"2008","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.steroids.2020.108661_b0495","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1096\/fj.15-276840","article-title":"The microbiota shifts the iron sensing of intestinal cells","volume":"30","author":"Deschemin","year":"2016","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.steroids.2020.108661_b0500","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/ph11040098","article-title":"Gut microbiota and iron: The crucial actors in health and disease","volume":"11","author":"Yilmaz","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.steroids.2020.108661_b0505","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.4049\/jimmunol.1400278","article-title":"Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota","volume":"193","author":"Shanmugam","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.steroids.2020.108661_b0510","doi-asserted-by":"crossref","unstructured":"G.M. Rosen, S. Morrissette, A. Larson, P. Stading, K.H. Griffin, T.L. Barnes, Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency, The Journal of pediatrics 207 (2019) 192-197. e1.","DOI":"10.1016\/j.jpeds.2018.12.026"},{"key":"10.1016\/j.steroids.2020.108661_b0515","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3389\/fimmu.2018.02123","article-title":"Efficacy of lactoferrin oral administration in the treatment of anemia and anemia of inflammation in pregnant and non-pregnant women: An interventional study","volume":"9","author":"Lepanto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.steroids.2020.108661_b0520","doi-asserted-by":"crossref","unstructured":"T. Huda, M. Dibley, S.E. Arifeen, S. Islam, N. Ali, S. Raihana, M. Rahman, F. Qadri, R. Raqib, W.T.-. Mordi, Assessing the Efficacy of Bovine Lactoferrin to Correct Iron Deficiency Anemia in Non-pregnant Non-lactating Women: A Randomized Controlled Trial (FS08-02-19), Current developments in nutrition 3(Supplement_1) (2019) nzz044. FS08-02-19.","DOI":"10.1093\/cdn\/nzz044.FS08-02-19"},{"issue":"9","key":"10.1016\/j.steroids.2020.108661_b0525","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/00016340903117994","article-title":"Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study","volume":"88","author":"Nappi","year":"2009","journal-title":"Acta obstetricia et gynecologica Scandinavica"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X20300866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X20300866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:06:28Z","timestamp":1758535588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X20300866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":105,"alternative-id":["S0039128X20300866"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2020.108661","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepcidin, an overview of biochemical and clinical properties","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2020.108661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108661"}}